On-demand insulin manufacturing using cell-free systems with an "on-column" conversion approach
Authors:
Open Access
- 20 June 2025
- journal article
- Published by Elsevier in New Biotechnology
- Vol. 89, 51-59
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Defense Advanced Research Projects Agency
- University of Maryland, Baltimore County
This publication has 65 references indexed in Scilit:
- All 3 Major Insulin Manufacturers Are Cutting Their Prices—Here’s What the News Means for Patients With DiabetesJAMA, 2023
- FkpA enhances membrane protein folding using an extensive interaction surfaceProtein Science, 2023
- A global perspective on the issue of access to insulinDiabetologia, 2021
- COVID-19 and type 1 diabetes: Challenges and actionsDiabetes Research and Clinical Practice, 2020
- Manufacturing biological medicines on demand: Safety and efficacy of granulocyte colony‐stimulating factor in a mouse model of total body irradiationBiotechnology Progress, 2020
- Optimizing cell‐free protein expression in CHO: Assessing small molecule mass transfer effects in various reactor configurationsBiotechnology and Bioengineering, 2017
- Insulin: a small protein with a long journeyProtein & Cell, 2010
- Efficient and scalable method for scaling up cell free protein synthesis in batch modeBiotechnology and Bioengineering, 2005
- Integrated production of human insulin and its C-peptideJournal of Biotechnology, 1996
- Computer‐aided process analysis and economic evaluation for biosynthetic human insulin production—A case studyBiotechnology and Bioengineering, 1995